Skip to content
NuProbe logo — Focused Genomics Panels

NuProbe

Focused Genomics Panels

Founded 2016 United States Houston, United States 25 employees Series B Total: $103.00M Biotechnology, Health Care

General Information

Company Name NuProbe
Founded Year 2016
Location United States Houston, United States
Employees 25
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with NuProbe. To contact NuProbe, visit nuprobe.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NuProbe compare?

A PDF of NuProbe and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NuProbe soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NuProbe

NuProbe, founded in 2016, is a biotechnology startup headquartered in the United States. The company specializes in the development and validation of high-sensitivity genomics panels. Their focus is on challenging DNA biomarkers such as CNVs, gene fusions, and low-frequency mutations.

Positioned within the vibrant Biotechnology and Health Care industries, NuProbe distinguishes itself with the ability to tackle intricate genetic anomalies, providing solutions tailored to cutting-edge genomic research and diagnostics.

Remarkably, the company secured a substantial $50.00M Series B investment on 02 June 2022. This funding round was supported by a strong consortium of investors, including Pappas Capital, BioTrack Capital, 上海涌铧投资管理有限公司, Sequoia Capital China, Pan-Lin Capital, CR-CP Life Science Fund, Deguan Capital, Haoreng Capital, and CICC Healthcare Investment Fund.

As an analyst, the company's robust investment backing and specialized focus suggest strong potential for growth and impact in the genomics sector.

Business keywords: Genomics, Molecular Diagnostics, DNA Biomarkers, CNVs, Gene Fusions, Low-Frequency Mutations, Cutting-Edge Technology, Sequencing, PCR, NGS, High-Sensitivity Panels, NuProbe, Biomarker Validation, Prototype Development

Services & Products

Assay Development
High-Sensitivity Genomics Panels
Low-Abundant Sequence Variant Detection
Biopharma Services
Custom Assay Development

Target Customers

Clinical and Research Laboratories Biopharmaceutical Companies Oncology Researchers Precision Medicine Practitioners

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $50.00M 9
Pappas Capital, BioTrack Capital +7
02 Jun 2022
Series B $42.00M 1
Ruomu Capital
11 Jan 2021
Venture Round Undisclosed -
01 Jan 2020
Series A $11.00M -
23 Apr 2018

NuProbe Alternatives & Competitors

View All Alternatives
NuProbe vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
NuProbe vs
Paragon Genomics
Paragon Genomics United States

Your NGS Panel Development and OEM Partner

Series A
17 employees
Biotechnology, Health Care
NuProbe vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care

FAQ About NuProbe

Focused Genomics Panels
NuProbe was founded in 2016.
NuProbe is headquartered in Houston, United States.
NuProbe operates in Biotechnology and Health Care. Its work centres on Genomics, Molecular Diagnostics, DNA Biomarkers and CNVs. Its customers include Clinical and Research Laboratories, Biopharmaceutical Companies and Oncology Researchers.
NuProbe has approximately 25 employees.
NuProbe has completed 4 funding rounds, raising a total of $103.00M. The latest funding stage is Series B.
NuProbe offers: Assay Development, High-Sensitivity Genomics Panels, Low-Abundant Sequence Variant Detection, Biopharma Services, Custom Assay Development.
Top alternatives and competitors to NuProbe include Synbio Technologies, Paragon Genomics, OncoDNA, Annoroad Genomics, Singlera Genomics Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NuProbe and Synbio Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NuProbe, https://bouncewatch.com/company/nuprobe, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout